Lupus has long been one of medicine’s most complex and underfunded diseases. Now, with a stronger clinical pipeline and growing industry interest, Lupus Ventures is stepping in to close the funding gap and prioritize return on mission over return on capital.
Feb 17, 2026
View all sectors
Browse all companies